Medicare Negotiated Drugs Can Face Immediate Generic, Biosimilar Substitution, CMS Proposal Confirms

 
• By Cathy Kelly
  
Policy aims to help promote generic, biosimilar uptake in Part D (Shutterstock)

More from Regulation

More from Generics Bulletin